Heart Pump Improves Survival After Severe Heart Attacks
Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks
Stay updated with breaking news from Danger Shock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks
First trial in a quarter-century to show mortality benefit in this desperately ill group
Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to a study presented at the American College of Cardiology's Annual Scientific Session.
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
“The NCSI Study demonstrates the benefit of following a protocolized approach to AMICS, which includes early implantation of Impella. We are impressed with the improved survival rates seen with the use of best practices compared to the stagnant historical survival rate,” said Dr. Basir. “It is important to emphasize that the majority of hospitals in the NCSI Study were large community-based programs where heart attack patients first present. Giving these care teams a safe and effective protocol to manage critically ill patients has saved many lives.” “NCSI is the largest prospective...